Daiichi Sankyo
Kartik Shukla has extensive experience in the pharmaceutical industry, currently serving as Executive Director for Hematology/Rare Cancer & New Product Planning at Daiichi Sankyo US since May 2005. Over the years, Kartik has held multiple leadership roles within the company, including Executive Director of US Marketing for Injectafer & Emerging Assets, Senior Director of the Iron Franchise & Multi-Channel Marketing, and Director of Multi-Channel Marketing. Career beginnings include a Pharmacy Manager position at Walgreens from January 2000 to October 2005. Kartik holds an MBA in Pharmaceutical Management and Marketing from Rutgers University - Newark and a BS in Pharmacy from Rutgers University.
This person is not in any teams
This person is not in any offices
Daiichi Sankyo
21 followers
Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Daiichi Sankyo Group and Ranbaxy Group. The Daiichi Sankyo Group segment comprises of Daiichi Sankyo Co., Ltd. and its subsidiaries. The Ranbaxy Group segment includes its core company, Ranbaxy Laboratories Ltd. Both group segments deal with business activities in prescription drugs and general pharmaceutical products. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.